LIFS Stock Chart & Stats
$0.13
>-$0.01(-99.00%)
At close: 4:00 PM EST
$0.13
>-$0.01(-99.00%)
Day’s Range― - ―
52-Week Range$0.13 - $0.13
Previous CloseN/A
Volume475.00
Average Volume (3M)N/A
Market Cap
$24.58K
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta-43.00
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.00
Shares Outstanding245,837,500
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
LIFS FAQ
What was Life Stem Genetics Inc’s price range in the past 12 months?
Life Stem Genetics Inc lowest stock price was $0.13 and its highest was $0.13 in the past 12 months.
What is Life Stem Genetics Inc’s market cap?
Life Stem Genetics Inc’s market cap is $24.58K.
When is Life Stem Genetics Inc’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Life Stem Genetics Inc’s earnings last quarter?
Currently, no data Available
Is Life Stem Genetics Inc overvalued?
According to Wall Street analysts Life Stem Genetics Inc’s price is currently Overvalued.
Does Life Stem Genetics Inc pay dividends?
Life Stem Genetics Inc does not currently pay dividends.
What is Life Stem Genetics Inc’s EPS estimate?
Life Stem Genetics Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Life Stem Genetics Inc have?
Life Stem Genetics Inc has 245,837,500 shares outstanding.
What happened to Life Stem Genetics Inc’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Life Stem Genetics Inc?
Currently, no hedge funds are holding shares in LIFS
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Life Stem Genetics Inc
Life Stem Genetics Inc., an enterprise currently in its development phase, is focused on establishing a global network of clinics that specialize in stem cell therapy. Its comprehensive suite of offerings includes nutraceuticals, medical supplements, and intravenous nutritional cocktails, in addition to stem cell banking services. The company provides a variety of stem cell treatments addressing degenerative conditions, cancer, and weight management, alongside anti-aging and anti-viral therapies. Also available are Adistem stem cell treatments tailored for orthopedic, neurological, and lung diseases, as well as hyperbaric oxygen therapy. Life Stem Genetics Inc. maintains a strategic collaborative agreement with American CryoStem Corporation. This company was founded in 2012 and operates from its base in Beverly Hills, California.
Ownership Overview
―
Insiders
―
Mutual Funds
<0.01% Other Institutional Investors
99.99% Public Companies and
Individual Investors